About FDA

FDA Commissioner

FDA Commissioner Scott Gottlieb, M.D.

Dr. Scott Gottlieb was sworn in as the 23rd Commissioner of Food and Drugs on May 11, 2017. Dr. Gottlieb is a physician, medical policy expert, and public health advocate who previously served as the FDA's Deputy Commissioner for Medical and Scientific Affairs and before that, as a senior advisor to the FDA Commissioner.

Read Dr. Gottlieb's Full Bio

"FDA always faces big challenges because of where it sits at the intersection of so many critical concerns. By virtue of the fact that people’s lives – quite literally – depend on what we do. Patient and consumer protection are at the heart of what we do. And I believe deeply in that fundamental mission of this agency."

Dr. Gottlieb

FDA’s 2018 Strategic Policy Roadmap

FDA’s 2018 Strategic Policy Roadmap continues our focus on healthy innovation and safer families, emphasizing battling addiction crises, innovation, consumer empowerment, and the FDA workforce. Read the Strategic Policy Roadmap

Watch FDA Commissioner Scott Gottlieb, MD, address FDA staff on FDA’s 2018 Strategic Policy Roadmap.disclaimer icon

Page Last Updated: 03/15/2019
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English